Literature DB >> 140828

Effect of fasting and streptozotocin in the obese-hyperglycemic (ob/ob) mouse. Apparent lack of a direct relationship between insulin binding and insulin effects.

Y Le Marchand, E G Loten, F Assimacopoulos-Jeannet, M E Forgue, P Freychet, B Jeanrenaud.   

Abstract

The decrease of insulin binding to plasma membranes of liver, adipose, and muscle tissues observed in obese-hyperglycemic (ob/ob) mice was reversed towards normal by prolonged fasting or streptozotocin treatment. The extent of this reversal was related to that of the decrease in hyperinsulinemia of the obese mice. In contrast, binding of glucagon to liver plasma membranes was little influenced by fasting or streptozotocin treatment of obese animals. The relationship between insulin binding and metabolic effects of the hormone did not appear to be identical in all tissues. In muscle, insulin binding and insulin effect on glucose uptake and metabolism changed in parallel--i.e., when binding increased, tissue sensitivity to the hormone increased. In the liver, the increase in insulin binding that followed fasting or streptozotocin treatment was not accompanied by any detectable metabolic effect of insulin on hepatic metabolism. A similar situation appeared to prevail in adipose tissue. The varying relationships observed between the state of insulin binding to membranes and the target tissue responsiveness to the hormone probably reflect the multiplicity of the factors operative in these processes and help us to understand why the over-all obese-hyperglycemic syndrome of ob/ob mice cannot be improved simply by decreasing endogenous hyperinsulinemia.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 140828     DOI: 10.2337/diab.26.6.582

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

Review 1.  Interactions polypeptide hormones with cell membrane specific receptors: studies with insulin and glucagon.

Authors:  P Freychet
Journal:  Diabetologia       Date:  1976-05       Impact factor: 10.122

Review 2.  An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause.

Authors:  B Jeanrenaud
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

3.  Insulin action and binding in isolated hepatocytes from fasted, streptozotocin-diabetic, and older, spontaneously obese rats.

Authors:  J M Cech; R B Freeman; J F Caro; J M Amatruda
Journal:  Biochem J       Date:  1980-06-15       Impact factor: 3.857

4.  Effects of glucagon and insulin on fatty acid synthesis and glycogen degradation in the perfused liver of normal and genetically obese (ob/ob) mice.

Authors:  G Y Ma; C D Gove; D A Hems
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

5.  Diabetes-induced functional and structural changes in insulin receptors from rat skeletal muscle.

Authors:  C F Burant; M K Treutelaar; M G Buse
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

6.  Insulin resistance in adipocytes from fed and fasted obese rats: dissociation of two insulin actions.

Authors:  J Stevens; M H Green; D L Kaiser; S L Pohl
Journal:  Mol Cell Biochem       Date:  1981-07       Impact factor: 3.396

7.  Studies on the mechanism of insulin resistance after injury in the mouse.

Authors:  K N Frayn; Y Le Marchand-Brustel; P Freychet
Journal:  Diabetologia       Date:  1978-05       Impact factor: 10.122

8.  Differential regulation of multiple hepatic protein tyrosine phosphatases in alloxan diabetic rats.

Authors:  J M Boylan; D L Brautigan; J Madden; T Raven; L Ellis; P A Gruppuso
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

9.  Insulin binding and insulin action in rat fat cells after adrenalectomy.

Authors:  H Häring; C Calle; A Bug; R Renner; K D Hepp; W Kemmler
Journal:  Diabetologia       Date:  1980-10       Impact factor: 10.122

10.  Immune responses of diabetic animals. Comparison of genetically obese and streptozotocin-diabetic mice.

Authors:  W K Nichols; J B Spellmann; R A Daynes
Journal:  Diabetologia       Date:  1978-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.